Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study

OBJECTIVE: Cognitive measures that are sensitive to biological markers of Alzheimer disease (AD) pathology are needed in order to (a) facilitate preclinical staging, (b) identify individuals who are at the highest risk for developing clinical symptoms and (c) serve as endpoints for evaluating the ef...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Int Neuropsychol Soc
Main Authors: Aschenbrenner, Andrew J., Balota, David A., Fagan, Anne M., Duchek, Janet M., Benzinger, Tammie L.S., Morris, John C.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2015
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610253/
https://ncbi.nlm.nih.gov/pubmed/26416094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1355617715000776
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים